Literature DB >> 31079439

Surgery of malignant motor-eloquent gliomas guided by sodium-fluorescein and navigated transcranial magnetic stimulation: a novel technique to increase the maximal safe resection.

Giovanni Raffa1, Thomas Picht2,3, Filippo F Angileri4, Michael Youssef2, Alfredo Conti4, Felice Esposito4, Salvatore M Cardali4, Peter Vajkoczy2, Antonino Germanò4.   

Abstract

BACKGROUND: Maximal safe resection is the goal of modern surgical treatment of high-grade gliomas (HGGs) located close to the motor cortex (M1) and/or the corticospinal tract (CST). Preoperative planning based on navigated transcranial magnetic stimulation (nTMS) and fluorescence-guided resection (FGR) using sodium-fluorescein have been separately described to increase the extent of resection (EOR) while preserving the motor pathway. We assessed the efficacy of the combination of these techniques for surgery of motor-eloquent HGGs.
METHODS: We enrolled patients with motor-eloquent HGGs operated at the Departments of Neurosurgery of the University of Messina, Italy, and of the Charitè Universitatsmedizin Berlin, Germany, between 2016 and 2019. All patients underwent nTMS mapping of M1, and nTMS-based DTI tractography of CST. Tumor resection was guided by intraoperative neurophysiological mapping (IONM) supported by sodium-fluorescein fluorescence and by intraoperative visualization of the nTMS-based information through neuronavigation. EOR and new permanent motor deficits were compared with a historical control group of patients operated exclusively with IONM guidance.
RESULTS: Seventy-nine patients were enrolled, while 55 patients were included as controls. The gross total resection (GTR) rate was significantly higher in patients operated using nTMS + FGR compared with controls (64.5% vs. 47.2%, P=0.04). As well, postoperative new permanent motor deficits were reduced in the study group vs. controls (11.4% vs. 20%).
CONCLUSIONS: In this series, the combination of sodium-fluorescein FGR with nTMS-based planning improved surgical treatment of motor-eloquent HGGs. It represents a valuable support to IONM-guided resection, increasing the GTR rate while reducing the occurrence of permanent motor deficits.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31079439     DOI: 10.23736/S0390-5616.19.04710-6

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  4 in total

Review 1.  Assessing the Capabilities of Transcranial Magnetic Stimulation (TMS) to Aid in the Removal of Brain Tumors Affecting the Motor Cortex: A Systematic Review.

Authors:  Lucas Jose Vaz Schiavao; Iuri Neville Ribeiro; Cintya Yukie Hayashi; Eberval Gadelha Figueiredo; Andre Russowsky Brunoni; Manoel Jacobsen Teixeira; Gabriel Pokorny; Wellingson Silva Paiva
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-16       Impact factor: 2.989

Review 2.  Current Status of Neuromodulation-Induced Cortical Prehabilitation and Considerations for Treatment Pathways in Lower-Grade Glioma Surgery.

Authors:  Ryan P Hamer; Tseng Tsai Yeo
Journal:  Life (Basel)       Date:  2022-03-22

3.  Editorial: nTMS, Connectivity and Neuromodulation in Brain Tumor Patients.

Authors:  Giovanni Raffa; Thomas Picht; András Büki; Antonino Germanò
Journal:  Front Neurol       Date:  2022-04-06       Impact factor: 4.086

4.  Mapping and Preserving the Visuospatial Network by repetitive nTMS and DTI Tractography in Patients With Right Parietal Lobe Tumors.

Authors:  Giovanni Raffa; Maria Catena Quattropani; Giuseppina Marzano; Antonello Curcio; Vincenzo Rizzo; Gabriella Sebestyén; Viktória Tamás; András Büki; Antonino Germanò
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.